Explore more publications!
Turkmenistan Health News
Submit Press Release

Turkmenistan Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Turkmenistan Health News.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 16, 2025

AVITA Medical Announces CEO Transition
October 16, 2025

AVITA Medical Announces CEO Transition

Indeterminate GlobeNewswire
Disc Medicine Announces Receipt of FDA Commissioner’s National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP)
October 16, 2025

Disc Medicine Announces Receipt of FDA Commissioner’s National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP)

Indeterminate GlobeNewswire
Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants
October 16, 2025

Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire
Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details
October 16, 2025

Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details

Indeterminate GlobeNewswire
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
October 16, 2025

Globus Medical Schedules Third Quarter Earnings Release and Conference Call

Indeterminate GlobeNewswire
atai Life Sciences Announces Proposed Public Offering of Common Shares
October 16, 2025

atai Life Sciences Announces Proposed Public Offering of Common Shares

Indeterminate GlobeNewswire
atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression
October 16, 2025

atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression

Indeterminate GlobeNewswire
WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective October 21, 2025
October 16, 2025

WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective October 21, 2025

Indeterminate GlobeNewswire
LifeStance to Host Third Quarter 2025 Earnings Conference Call on November 6, 2025
October 16, 2025

LifeStance to Host Third Quarter 2025 Earnings Conference Call on November 6, 2025

Indeterminate GlobeNewswire
Lite Strategy Celebrates 14th Anniversary of Litecoin, Taps Institutional Signals Ahead of 2026
October 16, 2025

Lite Strategy Celebrates 14th Anniversary of Litecoin, Taps Institutional Signals Ahead of 2026

Indeterminate GlobeNewswire
Seer to Report Third Quarter 2025 Financial Results on November 6, 2025
October 16, 2025

Seer to Report Third Quarter 2025 Financial Results on November 6, 2025

Indeterminate GlobeNewswire
RxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting
October 16, 2025

RxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting

Indeterminate GlobeNewswire
Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update
October 16, 2025

Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update

Indeterminate GlobeNewswire
I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences
October 16, 2025

I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences

Indeterminate GlobeNewswire
Galapagos Announces Appointment of Fred Blakeslee as General Counsel
October 16, 2025

Galapagos Announces Appointment of Fred Blakeslee as General Counsel

Indeterminate GlobeNewswire
Galapagos kondigt benoeming aan van Fred Blakeslee als General Counsel
October 16, 2025

Galapagos kondigt benoeming aan van Fred Blakeslee als General Counsel

Indeterminate GlobeNewswire
Taysha Gene Therapies Regains Full Rights to Lead TSHA-102 Program in Clinical Evaluation for the Treatment of Rett Syndrome
October 16, 2025

Taysha Gene Therapies Regains Full Rights to Lead TSHA-102 Program in Clinical Evaluation for the Treatment of Rett Syndrome

Indeterminate GlobeNewswire
Praxis Precision Medicines, Inc. Announces Proposed Public Offering
October 16, 2025

Praxis Precision Medicines, Inc. Announces Proposed Public Offering

Indeterminate GlobeNewswire
Theriva™ Biologics anuncia una operación de incentivo de warrants por un importe bruto de 4 millones de dólares
October 16, 2025

Theriva™ Biologics anuncia una operación de incentivo de warrants por un importe bruto de 4 millones de dólares

Indeterminate GlobeNewswire
Le R&D Day de Cellectis souligne le potentiel de lasmé-cel pour combler un besoin médical majeur non satisfait chez les patients atteints de LAL-B en rechute ou réfractaire
October 16, 2025

Le R&D Day de Cellectis souligne le potentiel de lasmé-cel pour combler un besoin médical majeur non satisfait chez les patients atteints de LAL-B en rechute ou réfractaire

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions